spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 22 September 2009
doi: 10.1242/jcs.048090


Journal of Cell Science 122, 3703-3714 (2009)
Published by The Company of Biologists 2009
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow All Versions of this Article:
jcs.048090v1
122/20/3703    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Goodger, Z. V.
Right arrow Articles by Konietzko, U.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodger, Z. V.
Right arrow Articles by Konietzko, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway

Zoë V. Goodger1, Lawrence Rajendran2,3, Annette Trutzel1, Bernhard M. Kohli1, Roger M. Nitsch1 and Uwe Konietzko1,*

1 Psychiatry Research, University of Zurich, August-Forel Strasse 1, 8008 Zurich, Switzerland
2 Systems and Cell Biology of Neurodegeneration, University of Zurich, August-Forel Strasse 1, 8008 Zurich, Switzerland
3 Max-Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, 01307 Dresden, Germany

* Author for correspondence (uwekon{at}bli.uzh.ch)

Accepted 22 July 2009

Proteolytic processing of the amyloid precursor protein (APP) occurs via two alternative pathways, localized to different subcellular compartments, which result in functionally distinct outcomes. Cleavage by a β-{gamma} sequence generates the Aβ peptide that plays a central role in Alzheimer's disease. In the case of {alpha}-{gamma} cleavage, a secreted neurotrophic molecule is generated and the Aβ peptide cleaved and destroyed. In both cases, a cytosolic APP intracellular domain (AICD) is generated. We have previously shown that coexpression of APP with the APP-binding protein Fe65 and the histone acetyltransferase Tip60 results in the formation of nuclear complexes (termed AFT complexes), which localize to transcription sites. We now show that blocking endocytosis or the pharmacological or genetic inhibition of the endosomal β-cleavage pathway reduces translocation of AICD to these nuclear AFT complexes. AICD signaling further depends on active transport along microtubules and can be modulated by interference with both anterograde and retrograde transport systems. Nuclear signaling by endogenous AICD in primary neurons could similarly be blocked by inhibiting β-cleavage but not by {alpha}-cleavage inhibition. This suggests that amyloidogenic cleavage, despite representing the minor cleavage pathway of APP, is predominantly responsible for AICD-mediated nuclear signaling.

Key words: AICD, Amyloid precursor protein, Endocytosis, Nuclear signaling, Retrograde transport


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





© The Company of Biologists Ltd 2009